CLINICAL_TRIALS
trial_result
· 2015-05-25
Clinical Trial Update: Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis [Phase 3]
Summary
Phase 3 trial comparing two shortening regimens that include moxifloxacin for pulmonary tuberculosis; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Global Alliance for TB Drug Development | Conditions: Pulmonary Tuberculosis | Phase 3 | Status: COMPLETED | Results posted: 2015-05-25